Navigation Links
eDiets.com(R) Announces Q1 2008 Results
Date:5/13/2008

FORT LAUDERDALE, Fla., May 13 /PRNewswire-FirstCall/ -- eDiets.com, Inc. (Nasdaq: DIET), leveraging the power of the Internet to bring diet, fitness and healthy lifestyle solutions to everyone, today announced results for the quarter ended March 31, 2008.

Revenues for the first quarter of 2008 were $8.8 million, compared to $8.4 million in the prior year period. Net income (loss) for the quarter was $(5.1) million, or $(0.20) per diluted share, for the first quarter of 2008, compared to $(1.3) million, or $(0.05) per diluted share, for the first quarter of 2007.

Adjusted EBITDA*, defined as net income before interest, taxes, depreciation, amortization, stock-based compensation, severance charges and loss on disposition of assets, for the quarter ended March 31, 2008 was $(3.5) million compared to ($0.5) million in the prior year period.

First Quarter 2008 and Subsequent Highlights:

-- Hired Thomas Hoyer as Chief Financial Officer in March 2008

-- Launched alli(R) meal delivery program with GlaxoSmithKline

-- Debuted new creative for direct response TV campaign

-- Achieved over 600% increase in Q1 2008 meal delivery revenues from

prior year period

-- Signed seven B2B contracts year-to-date

"We started the first quarter with strong momentum in our meal delivery business, but ended the quarter with a disappointing performance due to two main issues," stated President and Chief Executive Officer, Steve Rattner. "The migration to our new technology platform temporarily affected our operational abilities and inaccurate forecasting of our expanding fresh food meal delivery program led to larger than expected increases in meal delivery expenses. We have taken immediate acti
'/>"/>

SOURCE eDiets.com, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call
2. eDiets.com(R) Announces Q4 and Year End 2007 Results
3. eDiets.com(R) to Report First Quarter 2008 Results on Tuesday, May 13, 2008
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...AdamDreamHealer,s GlobalIntentionHealsProjectprove...fsomeoneatadistance.Over10,000participantssentheal...oredbyaquantitative-EEG.Thedatawasanalyzedbyworlde...ver,B.C.Adaminitiatedtheworld,slargestintentionalh...eoclipofaspecificvisualizationtobeusedbyallpartici...
(Date:11/24/2009)...of radiation oncologists use advanced imaging tech...ET), magnetic resonance imaging (MRI), and 4-dimen...eation (to locate the tumor and other areas at ris...he December issue of the Journal of the American ..., In defining the target, the radiation oncologis...
(Date:11/24/2009)...ed to a significantly higher risk of strokes and c...day in the British Medical Journal . , The rese...rganization,s Collaborating Centre for Nutrition, ...Hospital in Coventry, UK, and the European Society... based at the Department of Clinical and Experimen...
(Date:11/24/2009)...USNewswire/--OnFriday,November20,juniorfeatherweig...otheheadduringatitleboutinPhiladelphia.Hewasrushed...ewereconducted,hewasdeclaredbraindeadonSunday. ,...ementorganization(OPO)servingeasternPennsylvania,s...italaspartofstandardclinicalprocedurestodeterminei...
(Date:11/24/2009)...versity School of Medicine (BUSM) and the Boston U...dentified a number of proteins whose activation al... cells with almost 97 percent accuracy. In additio...tional strategy to analyze this data and specifica...rcuits) that are active in cancer and "dormant" in...
Breaking Medicine News(10 mins):Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:High salt intake linked to strokes and cardiovascular disease 2Health News:Paying Tribute to Boxer Francisco 'Paco' Rodriguez 2Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2
...try is aware of public concern regarding H1N1 flu ...c to protect itself against this virus. The trade ...pport the responsible sale and use of health-promo... swine flu. Furthermore, federal law does not allo...
...c health emergency due to the new H1N1 virus, also...Program at the Harvard School of Public Health con...out the outbreak, how they are responding and what...erned (46%) that they or someone in their immediat...
...al blogger and health 2.0 consultant, published a ...onals and patients can follow all the new cases ...ive and interactive maps that show the exact locat...t accurate information are the sites of World Heal...
...of problems , , FRIDAY, May 1 (HealthDay N...h getting a good night,s sleep could be in store f...ractivity disorder (ADHD). , The study of 281 chil...ly to have short-term or lifetime issues with inso...
...uch as: BeneChill, Maven Biotechnologies, BioTechP...Smart Technologies, CVAC Systems and many more. , ... Allergan Medical , Mr. Robert E. Grant, 39, joine...ed. Today, Allergan Medical leads the multi-billi...
...y Shaklee Corporation, the number one natural nutr...d vitamin D level is associated with metabolic syn...sease. , , The study results are currently being ...taining cardiovascular health. , , Roger Barn...
Other Medicine News:Health News:Industry Coalition Advises Against Use of Dietary Supplements as Swine Flu Remedy, Cure 2Health News:Industry Coalition Advises Against Use of Dietary Supplements as Swine Flu Remedy, Cure 3Health News:Survey finds nearly half of Americans concerned they or their family may get sick from swine flu 2Health News:Survey finds nearly half of Americans concerned they or their family may get sick from swine flu 3Health News:Treating Sleep Disorders May Ease ADHD Symptoms 2Health News:BIOCOM's 4th Annual DeviceFest and Exhibition 2Health News:Vitamin D Linked to HDL Cholesterol - Shaklee Corporation Research Links Vitamin D with Key Biomarkers for Metabolic Syndrome and Heart Disease 2
(Date:11/24/2009)..., WAYNE,N.J.,Nov.24/PRNewswire/--MAQUETCardio...logies,announcedtodaythatithassignedaguaranteedtwo...rouppurchasingorganizations,tobethesolesourceprovi... ,, Underthetermsoftheagreement,whichrunsthroug...siveproviderofbeatingheartdevicesanddisposablesupp...
(Date:11/24/2009)..., MOUNTAINVIEW,Calif.,Nov.24/PRNewswire/--Sat...ovidersofkidneydialysisservicesandamajorsponsorofn...nalDiseasesurvivorandchefEliasNasrallahinhiseffort.... ,, EliasNasrallahbuiltasuccessfulcareerasache...de-downfiveyearsago,whenhewasdiagnosedwithEndStage...
(Date:11/24/2009)..., CARLSBAD,Calif.,Nov.24/PRNewswire-FirstCall...erinantisensetherapeutics,todayannouncedthatmanage...tAnnualHealthCareConferenceonTuesday,December1,200...eaudiowebcastofthepresentationwillbeavailableonthe... www.isispharm.com .Areplayofthepresentationwillbe...
Breaking Medicine Technology:MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Haemacure and Angiotech Enter License Distribution and Supply Agreements for Haemacures All Human Fibrin Sealant and Thrombin Products 47796 1Haemacure and Angiotech Enter License Distribution and Supply Agreements for Haemacures All Human Fibrin Sealant and Thrombin Products 47796 2Haemacure and Angiotech Enter License Distribution and Supply Agreements for Haemacures All Human Fibrin Sealant and Thrombin Products 47796 3Haemacure and Angiotech Enter License Distribution and Supply Agreements for Haemacures All Human Fibrin Sealant and Thrombin Products 47796 4Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 1Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 2Duke University Health System Chooses SSI for Revenue Cycle Claims Management 47794 3Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 1Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 2Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma 12449 3
...ro-Inflammatory Effects in the Tumor Microenvironm...or Efficacy - - Studies Show Similar Results for ... Antibody -, SAN DIEGO and TUSTIN, Ca...asdaq: PPHM ) today reported that,preclinical stu... the,American Association for Cancer Research (AAC...
...il 15 MedImmune today announced,that it has advan...eatment,for patients with asthma, with the start o...targeting interleukin-13 (IL-13). One of the,studi...alia designed to,assess the potential of the anti-...pite optimal treatment. The company has also begun...
Other Medicine Technology:Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab 2Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab 3Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab 4MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 2MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 3
Bax
Finstruments 403 Plate Washer
96 PW Microplate Washer
Finstrip 4
Medicine Products: